- Release Date: 15/04/25 09:40
- Summary: First patient treated in the Phase II of the SECuRE trial
- Price Sensitive: Yes
- Download Document 333.19KB
- Forums
- ASX - By Stock
- CU6
- Ann: First patient treated in the Phase II of the SECuRE trial
CU6
clarity pharmaceuticals ltd
Add to My Watchlist
3.09%
!
$4.51

Ann: First patient treated in the Phase II of the SECuRE trial
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$4.51 |
Change
0.135(3.09%) |
Mkt cap ! $1.654B |
Open | High | Low | Value | Volume |
$4.37 | $4.64 | $4.36 | $16.94M | 3.740M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
22 | 34526 | $4.50 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.51 | 7357 | 21 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 1754 | 4.490 |
21 | 32191 | 4.480 |
17 | 37096 | 4.470 |
10 | 27921 | 4.460 |
16 | 107516 | 4.450 |
Price($) | Vol. | No. |
---|---|---|
4.500 | 46459 | 18 |
4.510 | 9233 | 11 |
4.520 | 13125 | 10 |
4.530 | 22778 | 8 |
4.540 | 18497 | 7 |
Last trade - 15.33pm 01/08/2025 (20 minute delay) ? |
Featured News
CU6 (ASX) Chart |
The Watchlist
AFP
AFT PHARMACEUTICALS LIMITED
Hartley Atkinson, CEO & Founder
Hartley Atkinson
CEO & Founder
Previous Video
Next Video
SPONSORED BY The Market Online